Nephros PE Ratio 2010-2025 | NEPH
Current and historical p/e ratio for Nephros (NEPH) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Nephros PE ratio as of July 07, 2025 is 57.57.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Nephros PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-07-07 | 4.08 | 58.29 | |
| 2025-03-31 | 1.72 | $0.07 | 24.57 |
| 2024-12-31 | 1.47 | $0.00 | 0.00 |
| 2024-09-30 | 1.71 | $-0.09 | 0.00 |
| 2024-06-30 | 2.11 | $-0.13 | 0.00 |
| 2024-03-31 | 2.19 | $-0.14 | 0.00 |
| 2023-12-31 | 3.46 | $-0.15 | 0.00 |
| 2023-09-30 | 1.48 | $-0.09 | 0.00 |
| 2023-06-30 | 1.55 | $-0.38 | 0.00 |
| 2023-03-31 | 1.07 | $-0.46 | 0.00 |
| 2022-12-31 | 1.16 | $-0.63 | 0.00 |
| 2022-09-30 | 0.91 | $-0.74 | 0.00 |
| 2022-06-30 | 1.53 | $-0.55 | 0.00 |
| 2022-03-31 | 4.40 | $-0.55 | 0.00 |
| 2021-12-31 | 5.90 | $-0.41 | 0.00 |
| 2021-09-30 | 8.77 | $-0.38 | 0.00 |
| 2021-06-30 | 10.15 | $-0.38 | 0.00 |
| 2021-03-31 | 6.65 | $-0.45 | 0.00 |
| 2020-12-31 | 8.58 | $-0.52 | 0.00 |
| 2020-09-30 | 7.23 | $-0.46 | 0.00 |
| 2020-06-30 | 8.39 | $-0.44 | 0.00 |
| 2020-03-31 | 6.30 | $-0.39 | 0.00 |
| 2019-12-31 | 9.95 | $-0.44 | 0.00 |
| 2019-09-30 | 8.05 | $-0.51 | 0.00 |
| 2019-06-30 | 5.49 | $-0.50 | 0.00 |
| 2019-03-31 | 4.32 | $-0.45 | 0.00 |
| 2018-12-31 | 5.13 | $-0.54 | 0.00 |
| 2018-09-30 | 5.43 | $-0.27 | 0.00 |
| 2018-06-30 | 5.47 | $-0.27 | 0.00 |
| 2018-03-31 | 3.78 | $-0.27 | 0.00 |
| 2017-12-31 | 4.05 | $-0.09 | 0.00 |
| 2017-09-30 | 2.70 | $-0.36 | 0.00 |
| 2017-06-30 | 2.07 | $-0.36 | 0.00 |
| 2017-03-31 | 3.46 | $-0.45 | 0.00 |
| 2016-12-31 | 3.29 | $-0.54 | 0.00 |
| 2016-09-30 | 3.33 | $-0.63 | 0.00 |
| 2016-06-30 | 2.31 | $-0.72 | 0.00 |
| 2016-03-31 | 2.34 | $-1.08 | 0.00 |
| 2015-12-31 | 1.94 | $-1.08 | 0.00 |
| 2015-09-30 | 3.33 | $-2.88 | 0.00 |
| 2015-06-30 | 6.39 | $-2.97 | 0.00 |
| 2015-03-31 | 5.40 | $-2.70 | 0.00 |
| 2014-12-31 | 7.11 | $-2.88 | 0.00 |
| 2014-09-30 | 6.98 | $-1.53 | 0.00 |
| 2014-06-30 | 10.62 | $-1.53 | 0.00 |
| 2014-03-31 | 5.76 | $-1.71 | 0.00 |
| 2013-12-31 | 3.82 | $-2.25 | 0.00 |
| 2013-09-30 | 10.80 | $-2.43 | 0.00 |
| 2013-06-30 | 8.10 | $-2.79 | 0.00 |
| 2013-03-31 | 7.11 | $-2.97 | 0.00 |
| 2012-12-31 | 10.71 | $-2.52 | 0.00 |
| 2012-09-30 | 12.60 | $-2.25 | 0.00 |
| 2012-06-30 | 18.00 | $-1.98 | 0.00 |
| 2012-03-31 | 9.45 | $-1.89 | 0.00 |
| 2011-12-31 | 6.21 | $-3.06 | 0.00 |
| 2011-09-30 | 17.10 | $-10.62 | 0.00 |
| 2011-06-30 | 6.75 | $-12.06 | 0.00 |
| 2011-03-31 | 3.96 | $-13.32 | 0.00 |
| 2010-12-31 | 18.00 | $-13.50 | 0.00 |
| 2010-09-30 | 50.40 | $-7.20 | 0.00 |
| 2010-06-30 | 64.80 | $-7.20 | 0.00 |
| 2010-03-31 | 198.00 | $-7.20 | 0.00 |
| 2009-12-31 | 140.40 | $-5.40 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.043B | $0.014B |
| Nephros develops advanced End Stage Renal Disease, or ESRD, therapy technology and products that would address both patient treatment needs and the clinical and financial needs of the treatment provider. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.904B | 28.13 |
| Boston Scientific (BSX) | United States | $154.336B | 38.64 |
| Stryker (SYK) | United States | $150.874B | 31.55 |
| EssilorLuxottica (ESLOY) | France | $127.819B | 0.00 |
| Medtronic (MDT) | Ireland | $113.364B | 16.07 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.609B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.066B | 26.28 |
| ResMed (RMD) | United States | $37.677B | 28.30 |
| GE HealthCare Technologies (GEHC) | United States | $34.831B | 16.54 |
| Agilent Technologies (A) | United States | $34.480B | 22.48 |
| Terumo (TRUMY) | Japan | $25.244B | 32.79 |
| Koninklijke Philips (PHG) | Netherlands | $23.274B | 16.33 |
| Insulet (PODD) | United States | $21.186B | 83.16 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.532B | 11.90 |
| Baxter (BAX) | United States | $15.914B | 11.88 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.262B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.846B | 23.82 |
| Lantheus Holdings (LNTH) | United States | $5.564B | 14.03 |
| Prestige Consumer Healthcare (PBH) | United States | $3.952B | 17.66 |
| Perrigo (PRGO) | Ireland | $3.739B | 9.48 |
| Haemonetics (HAE) | United States | $3.693B | 16.82 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.456B | 28.72 |
| ICU Medical (ICUI) | United States | $3.333B | 24.58 |
| QuidelOrtho (QDEL) | United States | $2.042B | 14.04 |
| LeMaitre Vascular (LMAT) | United States | $1.907B | 42.62 |
| AtriCure (ATRC) | United States | $1.572B | 0.00 |
| Acuren (TIC) | United States | $1.378B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.258B | 12.77 |
| Green Thumb Industries (GTBIF) | United States | $1.164B | 26.19 |
| Neogen (NEOG) | United States | $1.157B | 14.81 |
| Phibro Animal Health (PAHC) | United States | $1.135B | 14.51 |
| BioLife Solutions (BLFS) | United States | $1.085B | 0.00 |
| InMode (INMD) | Israel | $0.958B | 9.66 |
| Kestra Medical Technologies (KMTS) | United States | $0.805B | 0.00 |
| Owens & Minor (OMI) | United States | $0.712B | 5.90 |
| CeriBell (CBLL) | United States | $0.684B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.680B | 0.00 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.555B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.542B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.468B | 0.00 |
| Surmodics (SRDX) | United States | $0.429B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.363B | 13.33 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.360B | 0.00 |
| Quanterix (QTRX) | United States | $0.349B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| Cerus (CERS) | United States | $0.294B | 0.00 |
| ZimVie (ZIMV) | United States | $0.285B | 12.98 |
| Viemed Healthcare (VMD) | United States | $0.283B | 23.83 |
| Sanuwave Health (SNWV) | United States | $0.271B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.255B | 75.67 |
| Brainsway (BWAY) | Israel | $0.250B | 66.20 |
| Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.235B | 0.00 |
| Biote (BTMD) | United States | $0.231B | 6.49 |
| OraSure Technologies (OSUR) | United States | $0.230B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.192B | 0.00 |
| Organigram Global (OGI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.190B | 15.46 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| Exagen (XGN) | United States | $0.150B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.48 |
| MacroGenics (MGNX) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.087B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.084B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.077B | 0.00 |
| Zynex (ZYXI) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.86 |
| Safety Shot (SHOT) | United States | $0.030B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |